{"id":33657,"date":"2025-02-11T12:46:47","date_gmt":"2025-02-11T17:46:47","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_news&#038;p=33657"},"modified":"2025-02-13T14:17:09","modified_gmt":"2025-02-13T19:17:09","slug":"cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy","status":"publish","type":"cri_news","link":"https:\/\/www.cancerresearch.org\/es\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy","title":{"rendered":"Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy\u00a0"},"content":{"rendered":"\n<p><strong>NEW YORK, NY \u2013<\/strong> The Cancer Research Institute (CRI) is proud to announce its Fall 2024 class of CRI Irvington Postdoctoral Fellows and Immuno-Informatics Fellows, supporting pioneering scientists conducting transformative research in cancer immunotherapy. The CRI Irvington Postdoctoral Fellowship supports the training of exceptional postdoctoral researchers, preparing them to become future leaders in immuno-oncology. These exceptional researchers are investigating novel therapeutic strategies to harness the immune system against cancer, with projects spanning CAR T-cell therapy, tumor metabolism, computational immunology, and immune regulation.&nbsp;<\/p>\n\n\n\n<p>\u00abOur fellows represent the future of cancer immunotherapy, tackling some of the most complex challenges in the field with bold, innovative approaches,\u00bb said Dr. Alicia Zhou, CRI\u2019s Chief Executive Officer. \u00abTheir research will not only expand our fundamental understanding of cancer immunology but also bring us closer to new, more effective treatments for patients worldwide.\u00bb&nbsp;<\/p>\n\n\n\n<p><strong>Fall 2024 CRI Irvington Postdoctoral Fellows&nbsp;<\/strong><\/p>\n\n\n\n<p><em>(Supporting early-career scientists in their training and advancing immuno-oncology research)<\/em>&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/hannah-bell-md-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Hannah Bell, PhD<\/strong><\/a> \u2013 University of Michigan\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/jesse-boumelha-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Jesse Boumelha, PhD<\/strong><\/a> \u2013 Icahn School of Medicine at Mount Sinai&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-collins-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Joseph Collins, PhD<\/strong><\/a> \u2013 Boston Children&#8217;s Hospital&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/liuhui-fu-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Liuhui Fu, PhD<\/strong><\/a> \u2013 NYU Grossman School of Medicine&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/mingeum-jeong-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Mingeum Jeong, PhD<\/strong><\/a> \u2013 Weill Cornell Medicine&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/anukriti-mathur-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Anukriti Mathur, PhD<\/strong><\/a> \u2013 UMass Chan Medical School&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/kat-mueller-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Kat Mueller, PhD<\/strong><\/a> \u2013 Children&#8217;s Hospital of Philadelphia&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/parasvi-patel-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Parasvi Patel, PhD<\/strong><\/a> \u2013 Massachusetts General Hospital&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/harrison-sudholz-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Harrison Sudholz, PhD<\/strong><\/a> \u2013 University of California, Berkeley&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Aldo Ummarino, MD, PhD<\/strong><\/a> \u2013 Boston Children&#8217;s Hospital&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/rosa-vincent-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Rosa Vincent, PhD<\/strong><\/a> \u2013 Baylor College of Medicine&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/peter-wang-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Peter Wang, PhD<\/strong><\/a> \u2013 Massachusetts General Hospital&nbsp;<\/li>\n<\/ul>\n\n\n\n<p><strong>Fall 2024 CRI Immuno-Informatics Fellows&nbsp;<\/strong><\/p>\n\n\n\n<p><em>(Bridging quantitative and biological sciences to drive the next breakthroughs in cancer immunotherapy)<\/em>&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/anca-apavaloaei-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Anca Apavaloaei, PhD<\/strong><\/a> \u2013 Weill Cornell Medicine&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/hratch-baghdassarian-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Hratch Baghdassarian, PhD<\/strong><\/a> \u2013 Massachusetts Institute of Technology&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/liam-hendrikse-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Liam Hendrikse, PhD<\/strong><\/a> \u2013 University Health Network (Canada)&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Seongyeol Park, MD, PhD<\/strong><\/a> \u2013 Stanford University&nbsp;<\/li>\n<\/ul>\n\n\n\n<p>Since 1953, CRI has been at the forefront of advancing cancer immunotherapy by investing in the <strong>people<\/strong> driving scientific breakthroughs, deepening our understanding of <strong>biology<\/strong>, and leveraging cutting-edge <strong>data<\/strong> to accelerate discovery. With this new class of fellows, CRI continues its commitment to transforming cancer treatment through innovative research that harnesses the power of the immune system.&nbsp;<\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/IPF-Directory-sp-2.13.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Incrustado de IPF-Directory-sp-2.13.\"><\/object><a id=\"wp-block-file--media-d919e38f-adfa-4e05-8cba-8cb335dbe685\" href=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/IPF-Directory-sp-2.13.pdf\">IPF-Directory-sp-2.13<\/a><a href=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/IPF-Directory-sp-2.13.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-d919e38f-adfa-4e05-8cba-8cb335dbe685\">Download<\/a><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, NY \u2013 The Cancer Research Institute (CRI) is proud to announce its Fall 2024 class of CRI Irvington Postdoctoral Fellows and Immuno-Informatics Fellows, supporting pioneering scientists conducting transformative research in [&hellip;]<\/p>\n","protected":false},"featured_media":32160,"template":"","tags":[],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-33657","cri_news","type-cri_news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy\u00a0 - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy\u00a0 - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, NY \u2013 The Cancer Research Institute (CRI) is proud to announce its Fall 2024 class of CRI Irvington Postdoctoral Fellows and Immuno-Informatics Fellows, supporting pioneering scientists conducting transformative research in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-13T19:17:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/08\/CRI-Logo-7-19.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"440\" \/>\n\t<meta property=\"og:image:height\" content=\"440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy\",\"url\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy\",\"name\":\"Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy\u00a0 - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/08\/CRI-Logo-7-19.jpg\",\"datePublished\":\"2025-02-11T17:46:47+00:00\",\"dateModified\":\"2025-02-13T19:17:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/08\/CRI-Logo-7-19.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/08\/CRI-Logo-7-19.jpg\",\"width\":440,\"height\":440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Media Room Article\",\"item\":\"https:\/\/www.cancerresearch.org\/media-room\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy\u00a0 - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy","og_locale":"es_ES","og_type":"article","og_title":"Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy\u00a0 - Cancer Research Institute","og_description":"NEW YORK, NY \u2013 The Cancer Research Institute (CRI) is proud to announce its Fall 2024 class of CRI Irvington Postdoctoral Fellows and Immuno-Informatics Fellows, supporting pioneering scientists conducting transformative research in [&hellip;]","og_url":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy","og_site_name":"Cancer Research Institute","article_modified_time":"2025-02-13T19:17:09+00:00","og_image":[{"width":440,"height":440,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/08\/CRI-Logo-7-19.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy","url":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy","name":"Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy\u00a0 - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/08\/CRI-Logo-7-19.jpg","datePublished":"2025-02-11T17:46:47+00:00","dateModified":"2025-02-13T19:17:09+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/08\/CRI-Logo-7-19.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2024\/08\/CRI-Logo-7-19.jpg","width":440,"height":440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-announces-fall-2024-cri-irvington-and-immuno-informatics-fellows-advancing-cancer-immunotherapy#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Media Room Article","item":"https:\/\/www.cancerresearch.org\/media-room"},{"@type":"ListItem","position":3,"name":"Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news\/33657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/32160"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=33657"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tags?post=33657"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=33657"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=33657"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=33657"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=33657"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=33657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}